Skip to main content

Table 2 EWGSOP2 sarcopenia prevalence based on grip strength, chair stand, or any criteria

From: Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016

EWGSOP2 algorithm

Sarcopenia classification

40–59 (n = 673)

60–64 (n = 717)

65–69 (n = 876)

70–74 (n = 643)

75–79 (n = 398)

80–84 (n = 191)

All (n = 3498)

Age-standardized prevalence (%)a

Grip strength

+

ALMheight2

No sarcopenia

668 (99.26)

713 (99.44)

871 (99.43)

635 (98.76)

388 (97.49)

175 (91.62)

3450 (98.63)

Probable sarcopenia

5 (0.74)

4 (0.56)

5 (0.57)

7 (1.09)

7 (1.76)

10 (5.24)

38 (1.09)

1.00

Confirmed sarcopenia

0 (0.00)

0 (0.00)

0 (0.00)

1 (0.16)

3 (0.75)

6 (3.14)

10 (0.29)

0.26

Chair stands

+

ALMheight2

No sarcopenia

662 (98.37)

698 (97.35)

837 (95.55)

593 (92.22)

357 (89.70)

152 (79.58)

3299 (94.31)

 

Probable sarcopenia

11 (1.63)

19 (2.65)

37 (4.22)

46 (7.15)

32 (8.04)

31 (16.23)

176 (5.03)

3.89

Confirmed sarcopenia

0 (0.00)

0 (0.00)

2 (0.23)

4 (0.62)

9 (2.26)

8 (4.19)

23 (0.66)

0.51

Any strength criteria + ALMheight2

No sarcopenia

659 (97.92)

695 (96.93)

833 (95.09)

586 (91.14)

350 (87.94)

140 (73.30)

3263 (93.28)

Probable sarcopenia

14 (2.08)

22 (3.07)

41 (4.68)

53 (8.24)

36 (9.05)

39 (20.42)

205 (5.86)

4.54

Confirmed sarcopenia

0 (0.00)

0 (0.00)

2 (0.23)

4 (0.62)

12 (3.02)

12 (6.28)

30 (0.86)

0.69

  1. Numbers are n (%). EWGSOP2 European Working Group on Sarcopenia in Older People revised definition, ALMheight2 Appendicular Lean Mass relative to squared body height. aTotal sample prevalence standardized according to European Populations 2013. The Tromsø Study 2015–16